United States

Back to map

Showing 141-150 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation University of Florida Allison Bayer Cures 01-September-2023 to 31-March-2026 $510.297,39
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943.983,20
Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space Carnegie Mellon University Adam Feinberg Cures 01-November-2024 to 31-October-2027 $950.000,00
Enhancing Human Stem Cell-Derived Islet Survival and Function Using SA-PD-L1-Presenting Microgels Washington University Jeffrey Millman Cures 01-August-2024 to 31-July-2027 $1.125.000,00
Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes Trustees of Indiana University Jon Piganelli Cures 01-August-2023 to 30-June-2025 $334.595,29
Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 University of Florida Todd Brusko Cures 01-September-2024 to 31-August-2026 $500.000,00
Allogeneic hypoimmunogenic Pancreatic Islets for Treatment of Diabetes in the Intra-Muscular Site The Regents of the University of California, San Francisco Tobias Deuse Cures 01-August-2024 to 31-July-2026 $799.998,40
Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets University of Kansas Medical Center Research Institute, Inc. Hubert Tse Cures 01-April-2024 to 31-March-2026 $599.998,25
Role of pericytes during type 1 diabetes pathogenesis University of Miami Luciana Mateus Goncalves Cures 01-March-2024 to 28-February-2027 $259.750,00
Endothelial cells for islet replacement in diabetes Stanford University Martin Neukam Cures 01-April-2024 to 31-March-2027 $251.600,00